Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
Masashi NishikuboYoshimitsu ShimomuraNobuhiro HiramotoNaohiko SawamuraTakako YamaguchiShigeo HaraTakayuki IshikawaPublished in: BMC nephrology (2021)
Drug-induced TMA occurs early after gemcitabine and cisplatin use in renal-limited form and is reversible when detected and managed in a timely manner. Urinalysis, which is simple and inexpensive and can be easily performed, is a beneficial screening tool for early-onset drug-induced TMA among patients who receive gemcitabine-dexamethasone-cisplatin therapy.